FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer's Drug Approval

Dr. Aaron S. Kesselheim resigned in mid-June from an advisory panel of the Food and Drug Administration after the approval of a new Alzheimer's drug.

	FDA Panel Member Tells Healthline Why He Resigned Over Alzheimer's Drug Approval Dr. Aaron S. Kesselheim resigned in mid-June from an advisory panel of the Food and Drug Administration after the approval of a new Alzheimer's drug. Read on Why Is the FDA Warning About Nitrite Poppers? READ ON The Price We Paid: How Reopenings Last Year Affected COVID-19 Hospitalizations, Deaths READ ON People on High-Deductible Plan More Likely to Avoid ER, Even If They Have Chest Pain READ ON Got the Hiccups? This L-Shaped Straw Device May Be the Cure You Need READ ON More Top Reads Who are you when it comes to your health? Take our personality quiz to discover more about how you prioritize your health. LET'S GO Follow Us View in browser Did a friend send you this email? Subscribe here. To see all newsletters, click here. Privacy Policy|Unsubscribe © 2021 Healthline Media 660 3rd Street, San Francisco, CA 94107